Shanghai Kehua Bio-Engineering Co.,Ltd (SHE:002022)
5.97
+0.04 (0.67%)
Apr 30, 2026, 3:04 PM CST
SHE:002022 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Net Income | -732.14 | -640.6 | -234.01 | 971.56 | 850.41 |
Depreciation & Amortization | 231.45 | 246.46 | 215.98 | 213.36 | 153.18 |
Other Amortization | 34.95 | 12.85 | 10.3 | 6.23 | 5.1 |
Loss (Gain) From Sale of Assets | -3.87 | -4.21 | -5.02 | -4.53 | -2.06 |
Asset Writedown & Restructuring Costs | 120.63 | 93.25 | 82.59 | 145.97 | 15.61 |
Loss (Gain) From Sale of Investments | -1.72 | -10.8 | -24.41 | -3.9 | 1.96 |
Provision & Write-off of Bad Debts | 156.15 | 187.77 | 14.08 | 73.33 | 14.56 |
Other Operating Activities | 46.44 | 92.58 | 194.36 | 820.69 | 542.92 |
Change in Accounts Receivable | 76.36 | 105.03 | 271.54 | -407.28 | -264.82 |
Change in Inventory | -5.21 | -34.89 | 197.21 | -536.6 | -57.91 |
Change in Accounts Payable | 40.88 | -80.24 | -1,127 | 948.64 | -185.36 |
Operating Cash Flow | 22.44 | -50.12 | -474.89 | 2,154 | 1,079 |
Operating Cash Flow Growth | - | - | - | 99.55% | -21.06% |
Capital Expenditures | -139.29 | -254.82 | -330.93 | -427.91 | -216.03 |
Sale of Property, Plant & Equipment | 8.1 | 6.27 | 16.34 | 22.3 | 7.26 |
Cash Acquisitions | - | - | - | -6.12 | - |
Divestitures | 1.5 | - | - | - | - |
Investment in Securities | -60 | 311.5 | -315 | - | -8.91 |
Other Investing Activities | 2.04 | 12.92 | 23.17 | 3.9 | 5.18 |
Investing Cash Flow | -187.66 | 75.87 | -606.42 | -407.82 | -212.49 |
Short-Term Debt Issued | - | - | - | 10.4 | 0.68 |
Long-Term Debt Issued | 611.92 | 399.78 | 199.57 | 159.53 | 269.23 |
Total Debt Issued | 611.92 | 399.78 | 199.57 | 169.93 | 269.91 |
Long-Term Debt Repaid | -425.67 | -892.95 | -232.17 | -233.81 | -573.57 |
Net Debt Issued (Repaid) | 186.25 | -493.17 | -32.6 | -63.87 | -303.66 |
Issuance of Common Stock | - | - | - | 0.7 | 5.09 |
Repurchase of Common Stock | - | -101.02 | - | -0.12 | -3.03 |
Common Dividends Paid | -15.45 | -24.44 | -318 | -854.8 | -117.88 |
Other Financing Activities | -13.52 | -155.52 | -446.63 | 142.95 | -136.3 |
Financing Cash Flow | 157.28 | -774.15 | -797.23 | -775.14 | -555.78 |
Foreign Exchange Rate Adjustments | 0.73 | 3.16 | 9.26 | 51.56 | -9.79 |
Net Cash Flow | -7.2 | -745.23 | -1,869 | 1,022 | 301.15 |
Free Cash Flow | -116.86 | -304.94 | -805.82 | 1,726 | 863.19 |
Free Cash Flow Growth | - | - | - | 99.92% | -22.20% |
Free Cash Flow Margin | -7.12% | -17.33% | -33.19% | 24.76% | 17.78% |
Free Cash Flow Per Share | -0.23 | -0.60 | -1.57 | 3.24 | 1.62 |
Cash Income Tax Paid | 53.63 | 86.74 | 133.52 | 686.58 | 508.21 |
Levered Free Cash Flow | 443.13 | -150.89 | -786.2 | 1,401 | 494.8 |
Unlevered Free Cash Flow | 457.7 | -124.5 | -758.86 | 1,426 | 519.89 |
Change in Working Capital | 170.55 | -27.42 | -728.77 | -69.07 | -502.47 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.